BioCentury
ARTICLE | Company News

Connex GmbH, Genmab, Institute National de la Sante et de la Recherche deal

July 21, 2003 7:00 AM UTC

GEN obtained rights from Connex and INSERM to an antibody targeting the E2 envelope glycoprotein on the hepatitis C virus (HCV). Both Connex and INSERM jointly own patents to the antibody. GEN will be...